DALE VOGES: Open Payments
NPI 1629663331 · ROCKVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$655 in 33 payments from 13 companies in 2025. Trend: 2023 $677 · 2024 $400 · 2025 $655
Food & beverage: $655
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $240 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $61 |
| Tandem Diabetes Care, Inc. | 3 | $52 |
| Radius Health, Inc. | 3 | $48 |
| Inari Medical, Inc. | 1 | $48 |
| Dexcom, Inc. | 2 | $45 |
| Antares Pharma, Inc. | 2 | $36 |
| Lilly USA, LLC | 2 | $34 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| Corcept Therapeutics | 1 | $21 |
Products named: Ozempic, JARDIANCE, t:slim X2 Insulin Pump with Control-IQ, Tymlos, FLOWTRIEVER CATHETER, S, Dexcom G6 Transmitter, XYOSTED, LEQVIO.
Industry payments across IN — which companies pay providers there.
